Moreover, we also showed that Rev-erb agonist decreased Il6 and Mcp1 production, Mmp9 expression, NF-κB and MAPKs activations, and neutrophil/M1 macrophage infiltrations in infarct and border myocardium during the acute phase of MI. Here, MMP9 is linked to myocardial infarction.